Capillary Technologies India Ltd
- Market Cap ₹ 0.00 Cr.
- Current Price ₹
- High / Low ₹ /
- Stock P/E 0.00
- Book Value ₹
- Dividend Yield %
- ROCE 1.88 %
- ROE 0.73 %
- Face Value ₹ 2.00
Pros
- Company has reduced debt.
- Debtor days have improved from 133 to 93.2 days.
Cons
- Company has low interest coverage ratio.
- Earnings include an other income of Rs.12.2 Cr.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
| Operating Profit |
| OPM % |
| Interest |
| Depreciation |
| Profit before tax |
| Tax % |
| EPS in Rs |
| Raw PDF |
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| 115 | 150 | 143 | 174 | |
| 101 | 213 | 162 | 141 | |
| Operating Profit | 14 | -63 | -19 | 33 |
| OPM % | 12% | -42% | -14% | 19% |
| 8 | 6 | 8 | 12 | |
| Interest | 2 | 9 | 16 | 7 |
| Depreciation | 4 | 24 | 25 | 35 |
| Profit before tax | 17 | -90 | -52 | 4 |
| Tax % | 0% | 0% | 0% | 0% |
| 17 | -90 | -52 | 4 | |
| EPS in Rs | 71.57 | -18.01 | -10.46 | 0.70 |
| Dividend Payout % | 0% | 0% | 0% | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 22% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | 107% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 1% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Equity Capital | 2 | 11 | 15 | 15 |
| Reserves | 30 | 194 | 451 | 463 |
| 20 | 135 | 76 | 52 | |
| 29 | 115 | 51 | 63 | |
| Total Liabilities | 82 | 455 | 592 | 592 |
| 3 | 41 | 57 | 76 | |
| CWIP | 0 | 6 | 3 | 0 |
| Investments | 0 | 133 | 356 | 417 |
| 79 | 277 | 175 | 98 | |
| Total Assets | 82 | 455 | 592 | 592 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Net Cash Flow |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|
| Debtor Days | 171 | 195 | 111 | 93 |
| Inventory Days | ||||
| Days Payable | ||||
| Cash Conversion Cycle | 171 | 195 | 111 | 93 |
| Working Capital Days | 78 | -126 | -49 | -104 |
| ROCE % | -8% | 2% |
Documents
Annual reports
No data available.